CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI)

CUSIP: 163572209

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM NEW
Total 13F shares
3,730,374
Share change
-274,296
Total reported value
$19,770,000
Price per share
$5.30
Number of holders
24
Value change
-$1,456,310
Number of buys
8
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) as of Q1 2017

As of 31 Mar 2017, CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,730,374 shares. The largest 10 holders included ACUTA CAPITAL PARTNERS, LLC, WELLINGTON MANAGEMENT GROUP LLP, ARS Investment Partners, LLC, VANGUARD GROUP INC, New Jersey Better Educational Savings Trust, BRIDGEWAY CAPITAL MANAGEMENT INC, First Light Asset Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, PERKINS CAPITAL MANAGEMENT INC, and COLUMBIA PARTNERS L L C INVESTMENT MANAGEMENT. This page lists 24 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.